Agilent Technologies is a global leader in providing scientific instruments, software, and services for laboratories in the life sciences, diagnostics, and applied chemical markets. The company specializes in developing innovative solutions that enable scientists and researchers to enhance their workflows, improve productivity, and achieve more accurate results across various applications, including pharmaceuticals, environmental testing, and food safety. Agilent’s commitment to advancing science is reflected in its extensive portfolio of cutting-edge technologies and collaborative approach to supporting customers in their quest for discovery and innovation. Read More
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Thursday as we examine the latest happenings in today's session.
Wall Street hovered slightly higher by midday Thursday, giving up a chunk of strong overnight gains in futures markets that were triggered by a federal court ruling suspending a large portion of President Donald Trump’s tari
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session.
Life sciences tools company Agilent Technologies (NYSE:A) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 6% year on year to $1.67 billion. Its non-GAAP EPS of $1.31 per share was 3.6% above analysts’ consensus estimates.
Agilent reported Q2 revenue of $1.67 billion and beat EPS estimates. The company raised its 2025 sales forecast and reaffirmed full-year earnings guidance.
Life sciences tools company Agilent Technologies (NYSE:A) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 6% year on year to $1.67 billion. Guidance for next quarter’s revenue was better than expected at $1.66 billion at the midpoint, 0.9% above analysts’ estimates. Its non-GAAP profit of $1.31 per share was 3.6% above analysts’ consensus estimates.
The regular session of the US market on Wednesday is now over, but let's get a preview of the after-hours session and explore the top S&P500 gainers and losers driving the post-market movements.
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.67 billion for the second quarter ended April 30, 2025, representing growth of 6.0% reported and up 5.3% core(1) compared with the second quarter of 2024.
After a sharp Tuesday rally fueled by optimism over improved U.S.-EU trade ties, Wall Street stalled midweek as rising Treasury yields reasserted pressure ahead of Nvidia Corp.
Agilent Technologies Inc. (NYSE: A) today announced August Specht, Ph.D., has been named the company’s Chief Technology Officer. Specht, previously vice president of Global R&D for the Chromatography and Mass Spectrometry Division at Thermo Fisher Scientific, will join Agilent on June 9.
Agilent Technologies Inc. (NYSE: A) today announced the latest enhancements to the Agilent 8850 Gas Chromatograph (GC), including compatibility with single and triple quadrupole mass spectrometry (MS) systems and related tools and technologies to improve laboratory productivity. The unique design and compact size of the 8850 GC make it one of the fastest and smallest benchtop GC/MS available. It is explicitly designed for labs that require high speed and high performance in a space-saving format.
Agilent Technologies Inc. (NYSE: A) today announced the launch of its latest innovation in liquid chromatography (LC)-mass detection: the Agilent InfinityLab Pro iQ Series. This groundbreaking series includes the InfinityLab Pro iQ and the InfinityLab Pro iQ Plus, each tailored with distinct features and capabilities to meet the diverse analytical needs of modern laboratories. These advanced, intelligent systems are particularly well-suited for analyzing essential molecules such as therapeutic small molecules, oligonucleotides, peptides, and proteins.
Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.
Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 24.8 cents per share of common stock. The quarterly dividend will be paid on July 23, 2025, to all shareholders of record as of the close of business on July 1, 2025.
Agilent Technologies Inc. (NYSE: A) today announced that Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder and CEO of Downtown Advisory, have been elected to its Board of Directors, effective May 21, 2025.
Agilent Technologies Inc. (NYSE: A) today announced that the Infinity III LC Series — the company’s latest liquid chromatography (LC) instruments — are the first Agilent instruments to receive the new My Green Lab® ACT® Ecolabel 2.0, further reinforcing Agilent’s commitment to sustainable scientific innovation. Designed for efficiency, upgradeability, and environmental responsibility, the Infinity III LC Series offers laboratories a forward-thinking approach to liquid chromatography.
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning.
Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell — along with CFO Bob McMahon — will participate in a fireside chat at the Jefferies Global Healthcare Conference at 10:30 a.m. Eastern on Wednesday, June 4, 2025, in New York City.
